biomedical research

Why Allele?

Allele provides you with tools that you will find very helpful. The two main motives for Allele developed products are:
1) To incorporate the most advanced technologies in the field
2) To provide equal utility as other companies’ equivalent products at a much more reasonable cost.

How did we do it? By developing technologies internally, in most cases with government grant funding, by in-licensing others’ discoveries, and by listening to you, our customers.

What else do we do? Conduct basic curiosity-driven research just like most of our customers. It helps to stay on the edge and connect to the community.

Tags: Allele, Allele Biotech, biomedical research, cost effectiveness, cost efficiency, DNA, Fluorescent proteins, iPS, low cost, Protein, reagents, RNAi, viruses

Tuesday, July 28th, 2009 Customer Feedback, Open Forum No Comments

$6.5 billion more to the NIH

On Feb 3^rd the U.S. Senate agreed to an amendment that would provide an additional $6.5 billion to the National Institutes of Health (NIH) for biomedical research as part of the American Recovery and Reinvestment Act of 2009.

Last week, the House of Representatives and the Senate Appropriations Committee voted for the American Recovery and Reinvestment Act, which included $3.5 billion in supplemental funding for the NIH. The total stimulus package, still being amended in the Senate, is now over $900 billion.

The Senate is still debating the bill and being encouraged to finish it as early as this Friday.

Tags: $6.5 billion, Allele Biotech, billion, biomedical research, budget, funding, grant, NIH, R&D, science budget

Thursday, February 5th, 2009 NIH Budget and You No Comments